返回
Predicting treatment response from longitudinal images using multi-task deep learning
DOI:10.1038/s41467-021-22188-y.png)
摘要
En 中文
Radiographic imaging is routinely used to evaluate treatment response in solid tumors. Current imaging response metrics do not reliably predict the underlying biological response. Here, we present a multi-task deep learning approach that allows simultaneous tumor segmentation and response prediction. We design two Siamese subnetworks that are joined at multiple layers, which enables integration of multi-scale feature representations and in-depth comparison of pre-treatment and post-treatment images. The network is trained using 2568 magnetic resonance imaging scans of 321 rectal cancer patients for predicting pathologic complete response after neoadjuvant chemoradiotherapy. In multi-institution validation, the imaging-based model achieves AUC of 0.95 (95% confidence interval: 0.91-0.98) and 0.92 (0.87-0.96) in two independent cohorts of 160 and 141 patients, respectively. When combined with blood-based tumor markers, the integrated model further improves prediction accuracy with AUC 0.97 (0.93-0.99). Our approach to capturing dynamic information in longitudinal images may be broadly used for screening, treatment response evaluation, disease monitoring, and surveillance. Radiographic imaging is routinely used to evaluate treatment response in solid tumors. Here, the authors present a multi-task deep learning approach that allows simultaneous tumor segmentation and response prediction from longitudinal images in a multi-center study on rectal cancer.
Keyword:
PATHOLOGICAL COMPLETE RESPONSE
RECTAL-CANCER
NEOADJUVANT CHEMORADIATION
RADIOMICS
WATCH
MULTICENTER
ALGORITHM
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
15.7
论文数:
9.4W
被引数:
91.2W
机构
引用论文
MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy
RADIOLOGY
IF15.2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries全球癌症统计2018: GLOBOCAN估计全球185个国家36种癌症的发病率和死亡率
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial
LANCET
IF88.5
End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography基于低剂量胸部ct的三维深度学习端到端肺癌筛查
NATURE MEDICINE
IF50
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer个性化循环肿瘤DNA分析检测乳腺癌新辅助治疗后残留病灶
High-performance medicine: the convergence of human and artificial intelligence高性能医学: 人类与人工智能的融合
NATURE MEDICINE
IF50

